Walgreens Boots Alliance (NASDAQ:WBA) Shares Down 1.5% – Time to Sell?

Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Free Report) shares were down 1.5% on Friday . The stock traded as low as $10.32 and last traded at $10.50. Approximately 4,740,193 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 17,069,490 shares. The stock had previously closed at $10.66.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Morgan Stanley cut their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Bank of America decreased their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Finally, TD Cowen decreased their target price on Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $13.38.

View Our Latest Stock Analysis on WBA

Walgreens Boots Alliance Price Performance

The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The firm’s 50-day moving average price is $9.41 and its two-hundred day moving average price is $13.20. The stock has a market cap of $9.26 billion, a PE ratio of -1.56, a PEG ratio of 1.06 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.67 EPS. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 2.85 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Walgreens Boots Alliance

Hedge funds and other institutional investors have recently bought and sold shares of the company. Iron Horse Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 1,300 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the last quarter. Continuum Advisory LLC lifted its stake in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares during the period. Strategic Investment Solutions Inc. IL acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at $34,000. Finally, New Covenant Trust Company N.A. purchased a new position in Walgreens Boots Alliance in the 1st quarter worth $35,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

About Walgreens Boots Alliance

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.